Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy

American Journal of Roentgenology

Volumn 200, Issue 4, 2013, Pages

  Roy, Catherine ^a   Foudi, Fatah ^a   Charton, Jeanne ^a   Jung, Michel ^b   Lang, Hervé ^a   Saussine, Christian ^a   Jacqmin, Didier ^a  

^a HÔPITAL CIVIL   (France)

^b CENTRE PAUL STRAUSS   (France)

Author keywords

Functional MRI; MRI; Prostate neoplasm; Recurrence

Indexed keywords

GADOTERATE MEGLUMINE; PROSTATE SPECIFIC ANTIGEN; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; ENDORECTAL COIL; EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROSTATE TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84878221898     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9106     Document Type: Article

References (35)

1. Boccon-Gibod L, Djavan WB, Hammerer P, et al. Management of prostate-specific antigen relapse in prostate cancer: a European consensus. Int J Clin Pract 2004; 58: 382-390
2. Schillaci O, Calabria F, Tavolozza M, et al. Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced (18) F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy. Eur J Nucl Med Mol Imaging 2012; 39: 589-596
3. De Visschere PJ, De Meerleer GO, Fütterer JJ, Villeirs GM. Role of MRI in follow-up after focal therapy for prostate carcinoma. AJR 2010; 194: 1427-1433
4. Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR 1997; 168: 379-385
5. Sella T, Schwartz LH, Swindle PW, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004; 231: 379-385
6. Sala E, Eberhardt SC, Akin O, et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 2006; 238: 176-183
7. Kim CK, Park BK, Park W, Kim SS. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 2010; 35: 246-252
8. Fütterer JJ, Engelbrecht MR, Jager GJ, et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils - local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 2007; 17: 1055-1065
9. Ocak I, Bernardo M, Metzger G, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR 2007; 189: 849; [web]W192-W201
10. Casciani E, Polettini E, Carmenini E, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR 2008; 190: 1187-1192
11. Cirillo S, Petracchini M, Scotti L, et al. Endorectal magnetic resonance imaging at 1.5 tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009; 19: 761-769
12. Coakley FV, Teh HS, Qayyum A, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004; 233: 441-448
13. Haider MA, Chung P, Sweet J, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 425-430
14. Rouvière O, Valette O, Grivolat S, et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor - correlation with biopsy findings. Urology 2004; 63: 922-927
15. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR 2007; 188: 91-98
16. Portalez D, Gauthier R, Leanchi P, et al. Prospective comparison of T2w-MRI and dynamic contrast- enhanced MRI, 3D-MR spectroscopic imaging or diffusion MRI in repeat TRUS-guided biopsies. Eur Radiol 2010; 20: 2781-2790
17. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast- enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241: 449-458
18. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005; 234: 804-814
19. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003; 229: 248-254
20. Deliveliotis C, Manousakas T, Chrisofos M, Skolarikos A, Delis A, Dimopoulos C. Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy. World J Urol 2007; 25: 309-313
21. Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001; 219: 432-439
22. Sella T, Schwartz LH, Hricak H. Retained seminal vesicles after radical prostatectomy: frequency, MRI characteristics, and clinical relevance. AJR 2006; 186: 539-546
23. Allen SD, Thompson A, Sohaib SA. The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging. Eur Radiol 2008; 18: 1281-1291
24. Sheaff MT, Baithun SI. Effects of radiation on the normal prostate gland. Histopathology 1997; 30: 341-348
25. Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008; 54: 589-600
26. Casciani E, Bertini L, Gualdi G. Re: Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. (letter) Eur Urol 2009; 55:e2-e3; author reply, e4-e5
27. Westphalen AC, Coakley FV, Roach M, McCulloch CE, Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 2010; 256: 485-492
28. Franiel T, Hamm B, Hricak H. Dynamic contrastenhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 2011; 21: 616-626
29. Rouvière O, Vitry T, Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol 2010; 20: 1254-1266
30. Isebaert S, De Keyzer F, Haustermans K, et al. Evaluation of semi-quantitative dynamic contrast- enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology. Eur J Radiol 2011; 81:e217-e222
31. Tan CH, Wang J, Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol 2011; 21: 593-603
32. Van As N, Charles-Edwards E, Jackson A, et al. Correlation of diffusion weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol 2008; 81: 456-462
33. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-262
34. Chen J, Daniel BL, Diederich CJ, et al. Monitoring prostate thermal therapy with diffusionweighted MRI. Magn Reson Med 2008; 59: 1365- 1372
35. Kim CK, Park BK, Lee HM. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging 2009; 29: 391-397